FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000963309> ?p ?o ?g. }

• W2000963309 endingPage "406" @default.
• W2000963309 startingPage "397" @default.
• W2000963309 abstract "Sarcomas, or tumors of connective tissue, represent roughly 20% of childhood cancers. Although the cure rate for sarcomas in general has significantly improved in the last 10 years, there continue to be subgroups that are difficult to treat. High-grade or metastatic soft-tissue sarcomas and rhabdomyosarcomas (RMS) of the extremities remain therapeutic challenges and their prognosis is often poor. The future of sarcoma therapy will likely include molecular approaches including gene/protein expression profiling and gene-based therapy. Most sarcomas harbor defects in the p53 or pRb pathways. The tumor suppressor p53 is central to regulation of cell growth and tumor suppression and restoring wild-type p53 function in pediatric sarcomas may be of therapeutic benefit. Studies with adenoviral-mediated p53 gene transfer have been conducted in many cancer types including cervical, ovarian, prostatic and head and neck tumors. Studies of this approach, however, remain limited in pediatric cancers, including sarcomas. Using three viral constructs containing cDNA for wild-type p53, mutant p53 (C135S) and lacZ, we studied the effect of adenoviral-mediated gene therapy in four pediatric sarcoma cell lines, RD and Rh4 (RMS), Rh1 (Ewing's sarcoma) and A204 (undifferentiated sarcoma). Using the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay, we have shown a dose-dependent decrease in cell viability 72 h post-treatment that occurs with Ad-wtp53 but not with Ad-mutp53. Cells treated with Ad-wtp53 show upregulation of the p53 downstream targets, p21CIP1/WAF1 and bax. Growth curves demonstrate suppression of cell growth over a period of 4 days and cells treated with Ad-wtp53 demonstrate a significant increase in sensitivity to the chemotherapeutic agents, cisplatin and doxorubicin. Our results indicate that restoration of wild-type p53 function in pediatric sarcoma cells could provide a basis for novel approaches to treatment of this disease." @default.
• W2000963309 created "2016-06-24" @default.
• W2000963309 creator A5042055198 @default.
• W2000963309 creator A5049199116 @default.
• W2000963309 creator A5057680441 @default.
• W2000963309 creator A5077271114 @default.
• W2000963309 creator A5080739769 @default.
• W2000963309 date "2004-12-24" @default.
• W2000963309 modified "2023-10-08" @default.
• W2000963309 title "Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin" @default.
• W2000963309 cites W1789215739 @default.
• W2000963309 cites W1827235876 @default.
• W2000963309 cites W1966477793 @default.
• W2000963309 cites W1967488943 @default.
• W2000963309 cites W1972359936 @default.
• W2000963309 cites W1988876819 @default.
• W2000963309 cites W1991494214 @default.
• W2000963309 cites W1994544856 @default.
• W2000963309 cites W1998397323 @default.
• W2000963309 cites W1999638259 @default.
• W2000963309 cites W2000963309 @default.
• W2000963309 cites W2005542290 @default.
• W2000963309 cites W2008434560 @default.
• W2000963309 cites W2024482562 @default.
• W2000963309 cites W2026104663 @default.
• W2000963309 cites W2028897352 @default.
• W2000963309 cites W2029014948 @default.
• W2000963309 cites W2029463633 @default.
• W2000963309 cites W2035711855 @default.
• W2000963309 cites W2036551179 @default.
• W2000963309 cites W2036672802 @default.
• W2000963309 cites W2037100222 @default.
• W2000963309 cites W2038249511 @default.
• W2000963309 cites W2042316019 @default.
• W2000963309 cites W2042513120 @default.
• W2000963309 cites W2046780997 @default.
• W2000963309 cites W2047586232 @default.
• W2000963309 cites W2048548716 @default.
• W2000963309 cites W2053291484 @default.
• W2000963309 cites W2054549064 @default.
• W2000963309 cites W2057793681 @default.
• W2000963309 cites W2060387821 @default.
• W2000963309 cites W2061474729 @default.
• W2000963309 cites W2066415180 @default.
• W2000963309 cites W2071826279 @default.
• W2000963309 cites W2072726665 @default.
• W2000963309 cites W2074815481 @default.
• W2000963309 cites W2077373711 @default.
• W2000963309 cites W2081745595 @default.
• W2000963309 cites W2083765984 @default.
• W2000963309 cites W2088297726 @default.
• W2000963309 cites W2088740611 @default.
• W2000963309 cites W2093134342 @default.
• W2000963309 cites W2093777854 @default.
• W2000963309 cites W2095750423 @default.
• W2000963309 cites W2100950671 @default.
• W2000963309 cites W2102563614 @default.
• W2000963309 cites W2103460784 @default.
• W2000963309 cites W2103478972 @default.
• W2000963309 cites W2117936052 @default.
• W2000963309 cites W2126679757 @default.
• W2000963309 cites W2139952278 @default.
• W2000963309 cites W2152858404 @default.
• W2000963309 cites W2157455826 @default.
• W2000963309 cites W2166663717 @default.
• W2000963309 cites W2168623057 @default.
• W2000963309 cites W2244995601 @default.
• W2000963309 cites W2313967848 @default.
• W2000963309 cites W2317345315 @default.
• W2000963309 cites W2318838242 @default.
• W2000963309 cites W2321283558 @default.
• W2000963309 cites W2413756145 @default.
• W2000963309 cites W61004016 @default.
• W2000963309 doi "https://doi.org/10.1038/sj.cgt.7700798" @default.
• W2000963309 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15618970" @default.
• W2000963309 hasPublicationYear "2004" @default.
• W2000963309 type Work @default.
• W2000963309 sameAs 2000963309 @default.
• W2000963309 citedByCount "38" @default.
• W2000963309 countsByYear W20009633092013 @default.
• W2000963309 countsByYear W20009633092015 @default.
• W2000963309 countsByYear W20009633092016 @default.
• W2000963309 countsByYear W20009633092018 @default.
• W2000963309 countsByYear W20009633092019 @default.
• W2000963309 countsByYear W20009633092022 @default.
• W2000963309 crossrefType "journal-article" @default.
• W2000963309 hasAuthorship W2000963309A5042055198 @default.
• W2000963309 hasAuthorship W2000963309A5049199116 @default.
• W2000963309 hasAuthorship W2000963309A5057680441 @default.
• W2000963309 hasAuthorship W2000963309A5077271114 @default.
• W2000963309 hasAuthorship W2000963309A5080739769 @default.
• W2000963309 hasBestOaLocation W20009633091 @default.
• W2000963309 hasConcept C104317684 @default.
• W2000963309 hasConcept C111599444 @default.
• W2000963309 hasConcept C121608353 @default.
• W2000963309 hasConcept C126322002 @default.
• W2000963309 hasConcept C142724271 @default.
• W2000963309 hasConcept C2776694085 @default.

• next